课题基金 / 基金详情

项目摘要

项目成果

D Wade Gibson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The herpesvirus maturational protease is essential for the production of infectious virus and is synthesized as a precursor that has multiple functions during capsid assembly. Since its discovery 12 years ago, it has received considerable attention as a possible target for antivirals, and in the past 7 years a wealth of information about this interesting, albeit challenging, enzyme has accumulated. The 28-kDa enzyme is derived from a 74-kDa precursor by autoproteolytic cleavage, first at the (M)aturational site near its carboxyl end, and then at the (R)elease site. R-site cleavage frees assemblin from the ---44-kDa carboxyl portion of the precursor. The proteolytic domain, called assemblin in cytomegaolvirus, has been cloned, purified, and studied in vitro. The enzyme is activated by dimerization but the dimer pair has two separate acitive sites, moreover, it differs remarkably from other serine proteases by its new fold (7- stranded [3 barrel) and catalytic triad (Ser-His-His). No comparable information is available about the precursor. Our objective is to learn more about this viral enzyme through biochemical and genetic studies, with particular attention to its precursor. The specific aims are intended to help accomplish that objective by (i) applying mutant viruses to study the mechanism of this protease during virus infection, (ii) developing a protease mutant whose activity can be switched on in cells and in vitro by chemical rescue, (iii) investigating the ability of two catalytic-site mutants to form a complementation complex with selective specificity for the maturational-cleavage site, (iv) taking advantage of recent findings to investigate the structure of the precursor and compare its enzymatic properties with those of assemblin, and (v) investigating requirements and consequences of dimerization by both forms of the enzyme. Results of this work are anticipated to provide useful new information about this novel member of the serine proteinase family, and contribute to development of inhibitors that will block its function. It is also likely that useful new information will be generated in the areas of viral proteinase mechanisms and herpesvirus replication.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/978-3-540-77349-8_11
发表时间: 2008
期刊: Current topics in microbiology and immunology
影响因子: --
作者: [Wade Gibson]
通讯作者: Wade Gibson
Independently cloned halves of cytomegalovirus assemblin, An and Ac, can restore proteolytic activity to assemblin mutants by intermolecular complementation.
独立克隆的巨细胞病毒装配蛋白 An 和 Ac 的一半可以通过分子间互补恢复装配蛋白突变体的蛋白水解活性。
DOI: 10.1128/jvi.71.2.956-964.1997
发表时间: 1997
期刊: Journal of virology.
影响因子: --
作者: [Hall,MR, Gibson,W]
通讯作者: Gibson,W
Chemical rescue of I-site cleavage in living cells and in vitro discriminates between the cytomegalovirus protease, assemblin, and its precursor, pUL80a.
活细胞和体外 I 位点裂解的化学拯救可区分巨细胞病毒蛋白酶、组装蛋白及其前体 pUL80a。
DOI: 10.1074/jbc.m506876200
发表时间: 2005
期刊: The Journal of biological chemistry
影响因子: --
作者: [McCartney,StephenA, Brignole,EdwardJ, Kolegraff,KeliN, Loveland,AmyN, Ussin,LaShonM, Gibson,Wade]
通讯作者: Gibson,Wade
Cytomegalovirus assembly protein precursor and proteinase precursor contain two nuclear localization signals that mediate their own nuclear translocation and that of the major capsid protein.
巨细胞病毒组装蛋白前体和蛋白酶前体含有两个核定位信号,介导其自身的核易位和主要衣壳蛋白的核易位。
DOI: 10.1128/jvi.72.10.7722-7732.1998
发表时间: 1998
期刊: Journal of virology
影响因子: 5.4
作者: [Plafker,SM, Gibson,W]
通讯作者: Gibson,W
8
    Establish and Apply In Vitro System for Human Cytomegalovirus Capsid Assembly
    • 批准号:
      8496701
    • 项目类别:
    • 资助金额:
      $22.84万
    • 财政年份:
      2012
    • 负责人:
      D Wade Gibson
    • 依托单位:
    Establish and Apply In Vitro System for Human Cytomegalovirus Capsid Assembly
    • 批准号:
      8385942
    • 项目类别:
    • 资助金额:
      $20.25万
    • 财政年份:
      2012
    • 负责人:
      D Wade Gibson
    • 依托单位:
    Cytomegalovirus UL80 Proteins:Interactions and Modifications that Impact Function
    • 批准号:
      8191332
    • 项目类别:
    • 资助金额:
      $24.6万
    • 财政年份:
      2011
    • 负责人:
      D Wade Gibson
    • 依托单位:
    Cytomegalovirus UL80 Proteins:Interactions and Modifications that Impact Function
    • 批准号:
      8263745
    • 项目类别:
    • 资助金额:
      $20.5万
    • 财政年份:
      2011
    • 负责人:
      D Wade Gibson
    • 依托单位:
    海外基金